Hospira (HSP) Tops Q1 EPS by 44c

Hospira (NYSE: HSP) reported Q1 EPS of $0.97, $0.44 better than the analyst estimate of $0.53. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.08 billion.

For earnings history and earnings-related data on Hospira (HSP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c